MMCM
WST icon

Murphy & Mullick Capital Management’s West Pharmaceutical WST Stock Holding History

Murphy & Mullick Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.59K Hold
10
– – ﹤0.01% 584
2026
Q1 		$2.51K Hold
10
– – ﹤0.01% 590
2025
Q4 		$2.75K Hold
10
– – ﹤0.01% 591
2025
Q3 		$2.62K Hold
10
– – ﹤0.01% 581
2025
Q2 		$2.39K Hold
10
– – ﹤0.01% 575
2025
Q1 		$2.24K Hold
10
– – ﹤0.01% 562
2024
Q4 		$3.28K Buy
+10
New +$3.15K ﹤0.01% 534

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Murphy & Mullick Capital Management's WST Position: Q2 2026 in Review

Murphy & Mullick Capital Management held its West Pharmaceutical (WST) position steady in Q2 2026 at 10 shares worth $3.59K. The position accounts for ﹤0.01% of the portfolio, ranked #584.

Murphy & Mullick Capital Management first reported a position in WST in Q4 2024 and has held it in 7 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Murphy & Mullick Capital Management held 10 shares of West Pharmaceutical worth $3.59K as of Q2 2026.
  • Murphy & Mullick Capital Management left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Murphy & Mullick Capital Management's portfolio in Q2 2026, its #584 holding.
  • Murphy & Mullick Capital Management first reported a position in West Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.